Zdrowie i gospodarka · 31/07/2024
FDA Announces Prescription Drug User Fee Rates for Fiscal Year 2025
The Food and Drug Administration is setting the fees for reviewing prescription drugs and biological products for fiscal year 2025, as mandated by the Prescription Drug User Fee Amendments of 2022.